Prostate Cancer
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses - Abstract
November 2, 2011
Overall and worst Gleason scores are equally good predictors of prostate cancer progression - Abstract
November 1, 2011
Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: A validation study - Abstract
November 1, 2011
Predictive value of positive surgical margins after radical prostatectomy for lymph node metastasis in locally advanced prostate carcinoma - Abstract
November 1, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: Results from a phase 1-2 study - Abstract
November 1, 2011
Editor's Commentary - A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy
November 1, 2011
Surgery for high-risk localized prostate cancer - Abstract
October 31, 2011
Focal therapy for prostate cancer - where are we in 2011? - Abstract
October 31, 2011
Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study - Abstract
October 31, 2011
What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? - Abstract
October 31, 2011
Prostate cancer with five different histological features: A case report and review of the literature - Abstract
October 28, 2011
The uncertain relationship between obesity and prostate cancer: An Italian biopsy cohort analysis - Abstract
October 28, 2011